Essential Fatty Acids in Adult ADHD — OCEAN-GER

Adult Attention Deficit Hyperactivity Disorder Clinical Trial

Official title:
The Relationship of Essential Fatty Acids to Cognitive, Electrophysiological and Behavioural Function in Adults With Attention Deficit Hyperactivity Disorder and Controls

Status Completed

Clinical Trial Summary

The aim of this project is to investigate the effect of a dietary supplementation with essential fatty acids in adults on cognitive functions related to attention and impulse control in the general population and in individuals with a diagnosis of attention deficit hyperactivity disorder (ADHD).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Adult Attention Deficit Hyperactivity Disorder
Attention Deficit Disorder with Hyperactivity
Hyperkinesis

Clinical Trial Details

NCT number	NCT01798381
Study type	Interventional
Source	Saarland University
Contact
Status	Completed
Phase	Phase 3
Start date	December 2012
Completion date	December 2015

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06000501` - Duration and Efficacy of Azstarys on Adult ADHD Symptoms and Executive Function in Early Evening	Phase 4
Completed	`NCT03721588` - Clinical and Suicidal Features of Urban, Turkish Middle Age Depressive Patients With Comorbid ADHD
Completed	`NCT03324581` - The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder	Phase 2
Active, not recruiting	`NCT06221930` - Researching the Effectiveness of Attexis, a Digital Health Application for Adults With Attention Deficit Hyperactivity Disorder	N/A
Completed	`NCT02160262` - Open-label Safety Study in Adults With ADHD	Phase 3
Completed	`NCT02276209` - Dasotraline Adult ADHD Study	Phase 3
Completed	`NCT01692782` - Adult Attention Deficit Hyperactivity Disorder	Phase 2
Completed	`NCT00553319` - Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence	Phase 2/Phase 3